Smallpox vaccines for biodefense: need and feasibility (Q22305942)

Europe PubMed Central

title

Smallpox vaccines for biodefense: need and feasibility (English)

0 references

0 references

1 reference

Andrew W Artenstein

1

Andrew W

Artenstein

1 reference

PubMed

PubMed publication ID

18844596

6 April 2023

John D Grabenstein

series ordinal

2

author given names

John D

author last names

Grabenstein

1 reference

PubMed

PubMed publication ID

18844596

Expert Review of Vaccines

6 April 2023

language of work or name

English

0 references

publication date

October 2008

0 references

published in

0 references

volume

7

0 references

issue

8

0 references

page(s)

1225-1237

0 references

cites work

The history of vaccines and immunization: familiar patterns, new challenges

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Edward Jenner's Inquiry; a bicentenary analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Immunization to protect the US Armed Forces: heritage, current practice, and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

New smallpox case seems lab-caused

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Smallpox as a Biological Weapon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Diagnosis and management of smallpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

New generation smallpox vaccines: a review of preclinical and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Response to smallpox vaccine in persons immunized in the distant past

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Adventitious agents and smallpox vaccine in strategic national stockpile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Clonal vaccinia virus grown in cell culture as a new smallpox vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

LC16m8: an attenuated smallpox vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Modified vaccinia Ankara: potential as an alternative smallpox vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Smallpox vaccines: Past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

NYVAC: a highly attenuated strain of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Complications of smallpox vaccination, 1968.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Smallpox vaccination: a review, part II. Adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Encephalitis complicating smallpox vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

US Civilian Smallpox Preparedness and Response Program, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Contact vaccinia--transmission of vaccinia from smallpox vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

US military smallpox vaccination program experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Analysis of cases reported as generalized vaccinia during the US military smallpox vaccination program, December 2002 to December 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Adverse events associated with smallpox vaccination in the United States, January-October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

A different view of smallpox and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

The detection of monkeypox in humans in the Western Hemisphere.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Planning for smallpox outbreaks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Smallpox vaccine and its stockpile in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Validation of a screening instrument to identify persons for exclusion from smallpox vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

A model for a smallpox-vaccination policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Healthcare workers who elected not to receive smallpox vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Predictors of smallpox vaccination among healthcare workers and other first responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Reactions to small pox vaccine in naïve and previously-vaccinated individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Unintended Smallpox Vaccination of HIV-1--Infected Individuals in the United States Military

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Monitoring the Safety of a Smallpox Vaccination Program in the United States: Report of the Joint Smallpox Vaccine Safety Working Group of the Advisory Committee on Immunization Practices and the Armed Forces Epidemiological Board

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

Comparison of military and civilian reporting rates for smallpox vaccine adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Smallpox vaccination and ischemic coronary events in healthy adults

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Edward Jenner and the history of smallpox and vaccination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Reducing the Dose of Smallpox Vaccine Reduces Vaccine‐Associated Morbidity without Reducing Vaccination Success Rates or Immune Responses

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Risks of smallpox vaccination complications in the United States

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Legal implications of the Smallpox Vaccination Program

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Mass smallpox vaccination and cardiac deaths, New York City, 1947.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

History of U.S. military contributions to the study of vaccines against infectious diseases

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Smallpox: the triumph over the most terrible of the ministers of death

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Evaluation of 21st-century risks of smallpox vaccination and policy options

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021

Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.8.1225

7 January 2021